AMA Update 124: The FDA on Paxlovid and COVID-19: What physicians need to know, Part II
In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.